This list is an analysis based on recent market events. It's not an investment recommendation.
About
Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.
The current price of 8279.TWO is TWD78.20 TWD — it has increased by +0.13% in the past 24 hours. Watch Syngen Biotech stock price performance more closely on the chart.
What is Syngen Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Syngen Biotech stocks are traded under the ticker 8279.TWO.
Is Syngen Biotech stock price growing?▼
8279.TWO stock has fallen by -1.64% compared to the previous week, the month change is a -7.57% fall, over the last year Syngen Biotech has showed a -37.44% decrease.
What is Syngen Biotech market cap?▼
Today Syngen Biotech has the market capitalization of 2.12B
When is the next Syngen Biotech earnings date?▼
Syngen Biotech is going to release the next earnings report on November 18, 2026.
What is Syngen Biotech revenue for the last year?▼
Syngen Biotech revenue for the last year amounts to 2.14B TWD.
What is Syngen Biotech net income for the last year?▼
8279.TWO net income for the last year is 271.59M TWD.
Does Syngen Biotech pay dividends?▼
Yes, 8279.TWO dividends are paid annual. The last dividend per share was 5 . As of today, Dividend Yield (FWD)% is 6.4%.
How many employees does Syngen Biotech have?▼
As of September 24, 2026, the company has 554 employees.
In which sector is Syngen Biotech located?▼
Syngen Biotech operates in the Health & Wellness sector.
When did Syngen Biotech complete a stock split?▼
The last stock split for Syngen Biotech was on July 09, 2018 with a ratio of 1100:1000.
Where is Syngen Biotech headquartered?▼
Syngen Biotech is headquartered in Tainan City, Taiwan.